MaxCyte

Download MaxCyte Flow Electroporation: Vaccine Research & Development

In the run-up to the World Vaccine Congress, MaxCyte has provided us with this whitepaper on Flow Electroporation and its implications in vaccine research and development.  “MaxCyte’s proprietary flow electroporation is a universal transient transfection technology for rapid, high-quality cell transfection. Flow electroporation enables (co)transfection of a wide range of cells with DNA, RNA, siRNA, proteins, or cell lysates and …

China’s vaccine industry shoots up

Dr Sean Du, executive director of China's leading vaccine company Jiangsu Simcere Pharmaceuticals, stated that the worldwide market for vaccines has more than doubled from 2005 to 2008, having grown at a compound annual rate of 32 %.   From year 2008 to 2009, vaccine sales was up by another 16 % and hit the mark of $22.1 billion in …